US 10822426
Humanized anti-CD73 antibodies
granted A61PA61P35/00
Quick answer
US patent 10822426 (Humanized anti-CD73 antibodies) held by Corvus Pharmaceuticals, Inc. expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P35/00